Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aniello Cerrato
The Rationale for Druggability of CCDC6-tyrosine Kinase Fusions in Lung Cancer
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
WNT/Tcf1 Pathway Restricts Embryonic Stem Cell Cycle Through Activation of the Ink4/Arf Locus
PLoS Genetics
Evolution
Ecology
Genetics
Molecular Biology
Cancer Research
Systematics
Behavior
Related publications
Tyrosine Kinase Inhibitors in Lung Cancer
Hematology/Oncology Clinics of North America
Oncology
Hematology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
Elucidating the Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer Patients
Canadian Journal of Biotechnology
Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer
Experimental & Molecular Medicine
Receptor Tyrosine Kinase Expression of Circulating Tumor Cells in Small Cell Lung Cancer
Oncoscience
Cancer Research
Oncology
Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
Journal of Cancer
Oncology
Development of Crizotinib, a Rationally Designed Tyrosine Kinase Inhibitor for Non-Small Cell Lung Cancer
International Journal of Cancer
Cancer Research
Oncology